738 related articles for article (PubMed ID: 2598412)
1. Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Atassi G; Dumont P; Gosse C; Fournier JP; Gouyette A; Roger P
Cancer Chemother Pharmacol; 1989; 25(3):205-9. PubMed ID: 2598412
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenografts.
Dumont P; Atassi G; Roger P
In Vivo; 1990; 4(1):61-4. PubMed ID: 2103843
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
Bibby MC; Double JA; Morris CM
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1361-4. PubMed ID: 3181257
[TBL] [Abstract][Full Text] [Related]
4. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Atassi G; Dumont P; Kabbe HJ; Yoder O
Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
[TBL] [Abstract][Full Text] [Related]
5. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo].
Shkarin PIu; Sokolova IS; Gorbacheva LB; Sibel'dina LA
Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671
[No Abstract] [Full Text] [Related]
6. Synthesis and antitumour activity of a new series of nitrosoureido sugars.
Monneret C; Rissé S; Ardouin P; Gouyette A
Eur J Med Chem; 2000 Jan; 35(1):137-46. PubMed ID: 10733610
[TBL] [Abstract][Full Text] [Related]
7. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
Hill RP; Stanley JA
Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
[TBL] [Abstract][Full Text] [Related]
8. Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres.
Roos G; el Hag IA; Teder H; Stenram U
Anticancer Res; 1991; 11(1):13-6. PubMed ID: 2018346
[TBL] [Abstract][Full Text] [Related]
9. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
10. Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).
Bibby MC; Double JA
J Cancer Res Clin Oncol; 1986; 112(1):47-9. PubMed ID: 3733867
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
[TBL] [Abstract][Full Text] [Related]
12. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
Hill SR; Pollard LA; Bibby MC
Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
[TBL] [Abstract][Full Text] [Related]
13. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones.
Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity of several new pentopyranosyl-chloroethylnitrosoureas].
Grouiller A; Navarro ML; Nonga B; Molière P; Santini R; Voulot C; Pacheco H
C R Seances Soc Biol Fil; 1987; 181(2):128-36. PubMed ID: 2957032
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice.
McElhinney RS; McCormick JE; Bibby MC; Double JA; Atassi G; Dumont P; Pratesi G; Radacic M
Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750
[TBL] [Abstract][Full Text] [Related]
16. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
[TBL] [Abstract][Full Text] [Related]
17. Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma.
Trafalis DT; Camoutsis C; Papageorgiou A
Melanoma Res; 2005 Aug; 15(4):273-81. PubMed ID: 16034305
[TBL] [Abstract][Full Text] [Related]
18. CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
Fiebig HH; Widmer KH; Winterhalter BR; Löhr GW
Cancer Chemother Pharmacol; 1989; 23(6):337-40. PubMed ID: 2713955
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
